TY - JOUR
T1 - Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response
AU - Toney, Glenn M.
AU - Porter, James P.
N1 - Funding Information:
Acknowledgments. The authors are grateful to the DuPont Merck Pharmaceutical Co. for their generous donation of DuP 753, and to the Parke-Davis Pharmaceutical Co. for their gift of PD 123319. This study was supported by National Institutes of Health Grant R29 HL38993, and by the American Heart Association, Kentucky affiliate.
PY - 1993/2/12
Y1 - 1993/2/12
N2 - Intracerebroventricular (i.c.v.) angiotensin II (ANG II) increase vascular resistance and elicits a pressor response characterized by sympathetic nervous system activation (SNS component) and increased vasopressin (VP) secretion (VP component). This study examines the role of brain AT1 and AT2 ANG II receptors in mediating the pressor and renal hemodynamic effects of i.c.v. ANG II in conscious Sprague-Dawley rats. Mean arterial pressure, heart rate and renal vascular resistance responses to i.c.v. ANG II (100 ng in 5 μl) were determined 10 min after i.c.v. injection of either the AT1 receptor antagonist, DuP 753 (1.0, 2.5, 5.0, 10.0 μg), the AT2 receptor ligand, PD 123319 (3.5 × [10-6, 10-4, 10-2, 100 μg), or both. In control rats, i.c.v. DuP 753 prevented the pressor response and the increase in renal vascular resistance that occurred following i.c.v. ANG II in a dose-dependent manner (P < 0.05), while i.c.v. PD 123319 was without affect. When the VP- and SNS components were studied individually, by preventing the SNS component with intravenous (i.v.) chlorisondamine or the VP component with a V1 receptor antagonist (i.v.) similar results were obtained; DuP 753 prevented the SNS component and significantly reduced the VP component. These results indicate that both central ANG II pressor components are mediated primarily by brain AT1 receptors. However, doses of DuP 753 were more effective when combined with 3.5 μg of PD 123319 than when given alone (P < 0.05), suggesting that the pressor effects of i.c.v. ANG II may involve activation of multiple ANG II receptor subtypes.
AB - Intracerebroventricular (i.c.v.) angiotensin II (ANG II) increase vascular resistance and elicits a pressor response characterized by sympathetic nervous system activation (SNS component) and increased vasopressin (VP) secretion (VP component). This study examines the role of brain AT1 and AT2 ANG II receptors in mediating the pressor and renal hemodynamic effects of i.c.v. ANG II in conscious Sprague-Dawley rats. Mean arterial pressure, heart rate and renal vascular resistance responses to i.c.v. ANG II (100 ng in 5 μl) were determined 10 min after i.c.v. injection of either the AT1 receptor antagonist, DuP 753 (1.0, 2.5, 5.0, 10.0 μg), the AT2 receptor ligand, PD 123319 (3.5 × [10-6, 10-4, 10-2, 100 μg), or both. In control rats, i.c.v. DuP 753 prevented the pressor response and the increase in renal vascular resistance that occurred following i.c.v. ANG II in a dose-dependent manner (P < 0.05), while i.c.v. PD 123319 was without affect. When the VP- and SNS components were studied individually, by preventing the SNS component with intravenous (i.v.) chlorisondamine or the VP component with a V1 receptor antagonist (i.v.) similar results were obtained; DuP 753 prevented the SNS component and significantly reduced the VP component. These results indicate that both central ANG II pressor components are mediated primarily by brain AT1 receptors. However, doses of DuP 753 were more effective when combined with 3.5 μg of PD 123319 than when given alone (P < 0.05), suggesting that the pressor effects of i.c.v. ANG II may involve activation of multiple ANG II receptor subtypes.
KW - AT1
KW - AT2
KW - Angiotensin receptor subtype
KW - Blood pressure
KW - Intracerebroventricular
UR - http://www.scopus.com/inward/record.url?scp=0027400360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027400360&partnerID=8YFLogxK
U2 - 10.1016/0006-8993(93)91299-8
DO - 10.1016/0006-8993(93)91299-8
M3 - Article
C2 - 8453478
AN - SCOPUS:0027400360
SN - 0006-8993
VL - 603
SP - 57
EP - 63
JO - Brain Research
JF - Brain Research
IS - 1
ER -